ANATRA- anas barbariae tablet 
Anatra LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Active Ingredient

Anas barbariae. HPUS - 200 CK

Purpose

To reduce the duration and severity of cold & flu-like symptoms. The letters HPUS indicate that this ingredient is officially included in the Homeopathic Pharmacopeia of the United States.

Uses

Temporarily relieves cold & flu-like symptoms such as:

Warnings

Ask a Doctor before usein children under 2 years of age.
Stop use and ask a Doctor if symptoms persist for more than 3 days or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.

Directions

ANATRA may be taken regularly as a preventative.
Adults and children 2 years of age and older: Dissolve entire tablet in mouth every
6 hours, up to 3 times a day. Children under two years of age: Ask a Doctor.

Other Information

Do not use if carton is open and/or bottle is open.Each 0.775g dose contains 0.5g of sugar. Store at 68-77°F (20-25°C).

Inactive ingredients

Beta Carotene, Citric Acid, Crospovidone, Dextrose,Lactose, Magnesium Stearate, Nat. Orange Flavor, Reb. A (Stevia LeafExtract), Silicon Dioxide, Stearic Acid

Questions/Comments?

Distributed by Anatra LLC 3250 NE 1st Ave., Suite 305 Miami, FL 33137 (844) ANATRA-1

Product label

image descriptionimage descriptionimage descriptionimage description

ANATRA 
anas barbariae tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83641-001
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE (UNII: RN2HC612GY) (CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE - UNII:RN2HC612GY) CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE200 [hp_C]
Inactive Ingredients
Ingredient NameStrength
BETA CAROTENE (UNII: 01YAE03M7J)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
CROSPOVIDONE, UNSPECIFIED (UNII: 2S7830E561)  
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
REBAUDIOSIDE A (UNII: B3FUD0528F)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColororangeScoreno score
ShapeROUNDSize12mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:83641-001-0130 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product09/01/2023
2NDC:83641-001-0260 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product09/01/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other09/01/2023
Labeler - Anatra LLC (121482372)

Revised: 9/2023
Document Id: 056c4c48-8327-2219-e063-6294a90a391b
Set id: 4562fa87-ed88-42fb-b530-e600aea351d9
Version: 1
Effective Time: 20230915
 
Anatra LLC